Cancer genetics and cytogenetics

Keyphrases

Publications

volume 203, number 2, 2011

Berrak Gumuskaya, Murat Alper, Sema Hucumenoglu, Kadri Altundag, Aysegul Uner, Gulnur Guler
EGFR expression and gene copy number in triple-negative breast carcinoma. Cancer genetics and cytogenetics 203 (2) (2011)
Esra Manguoğlu, Sefik Güran, Deniz Yamaç, Taner Colak, Mehmet Simşek, Mehmet Baykara, Mustafa Akaydın, Güven Lüleci
Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients. Cancer genetics and cytogenetics 203 (2) (2011)
Inga-Marie Schaefer, Bastian Gunawan, László Füzesi, Manfred Blech, Josef Frasunek, Hagen Loertzer
Chromosomal imbalances in urinary bladder paraganglioma. Cancer genetics and cytogenetics 203 (2) (2011)
Youngil Koh, Dae-Young Kim, Sung-Hyo Park, Seung-Hyun Jung, Eunkyung Park, Hyeoung-Joon Kim, Sang Kyun Sohn, Young Don Joo, Seok Jin Kim, Ho-Jin Shin, Sung-Hyun Kim, Hong Suk Song, Jooseop Chung, Inho Kim, Sung-Soo Yoon, Byoung Kook Kim, Seung-Hun Shin, Yeun-Jun Chung, Seonyang Park
GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization. Cancer genetics and cytogenetics 203 (2) (2011)
Xiaosu Zhao, Qi Wu, Xinrong Fu, Bo Yu, Yong Shao, Hong Yang, Ming Guan, Xiaojun Huang, Wei Zhang, Jun Wan
Examination of copy number variations of CHST9 in multiple types of hematologic malignancies. Cancer genetics and cytogenetics 203 (2) (2011)
Machiko Kawamura, Hidefumi Kaku, Tateki Ito, Nobuaki Funata, Tomohiko Taki, Akira Shimada, Yasuhide Hayashi
FLT3-internal tandem duplication in a pediatric patient with t(8;21) acute myeloid leukemia. Cancer genetics and cytogenetics 203 (2) (2011)
Aref Al-Kali, Mohamad Cherry, Kristopher Kimmell, Jennifer Holter, William Kern, Bradley Gehrs, Howard Ozer, George Selby
A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)? Cancer genetics and cytogenetics 203 (2) (2011)
Min Jin Kim, Sun Young Cho, Myeong-Hee Kim, Jae Jin Lee, So Young Kang, Eun Hae Cho, Jungwon Huh, Hwi-Joong Yoon, Tae Sung Park, Woo-In Lee, Rolf Marschalek, Claus Meyer
FISH-negative cryptic PML-RARA rearrangement detected by long-distance polymerase chain reaction and sequencing analyses: a case study and review of the literature. Cancer genetics and cytogenetics 203 (2) (2011)
Neil E Kay, Jeanette E Eckel-Passow, Esteban Braggio, Scott Vanwier, Tait D Shanafelt, Daniel L Van Dyke, Diane F Jelinek, Renee C Tschumper, Thomas Kipps, John C Byrd, Rafael Fonseca
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy. Cancer genetics and cytogenetics 203 (2) (2011)
Arshad A Pandith, Zafar A Shah, Nighat P Khan, Roohi Rasool, Dil Afroze, Adfar Yousuf, Saleem Wani, Mushtaq Siddiqi
Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer genetics and cytogenetics 203 (2) (2011)
Amanda N Gruhl, Elena V Gostjeva, William G Thilly, Janna N Fomina, Firouz Darroudi
Human fetal/tumor metakaryotic stem cells: pangenomic homologous pairing and telomeric end-joining of chromatids. Cancer genetics and cytogenetics 203 (2) (2011)
Nyla A Heerema, John C Byrd, Paola S Dal Cin, Marie L Dell' Aquila, Prasad R K Koduru, Ayala Aviram, Stephanie A Smoley, Laura Z Rassenti, Andrew W Greaves, Jennifer R Brown, Kanti R Rai, Thomas J Kipps, Neil E Kay, Daniel L Van Dyke, null null
Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study. Cancer genetics and cytogenetics 203 (2) (2011)
Nathalie Douet-Guilbert, Audrey Basinko, Jean-Richard Eveillard, Frédéric Morel, Marie-Josée Le Bris, Nadia Guéganic, Clément Bovo, Angèle Herry, Christian Berthou, Marc De Braekeleer
Three rearrangements of chromosome 5 in a patient with myelodysplastic syndrome: an atypical deletion 5q, a complex intrachromosomal rearrangement of chromosome 5, and a paracentric inversion of chromosome 5. Cancer genetics and cytogenetics 203 (2) (2011)
Avery A Sandberg, Aurelia M Meloni-Ehrig
Cytogenetics and genetics of human cancer: methods and accomplishments. Cancer genetics and cytogenetics 203 (2) (2011)
M N Natasya Naili, C H Hasnita, A K Shamim, J Hasnan, M I Fauziah, M Y Narazah, A James, S Zulkiflee, M M T Nidzam, B A Zilfalil
Chromosomal alterations in Malaysian patients with nasopharyngeal carcinoma analyzed by comparative genomic hybridization. Cancer genetics and cytogenetics 203 (2) (2011)
Anna S Sowa, Aurelia M Meloni-Ehrig, April Tos, Jennifer Jahn, Shalini Dogra, Victor E Nava, Joann C Kelly, Philip N Mowrey
A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia. Cancer genetics and cytogenetics 203 (2) (2011)
Ute Gabriel, Michelle Giehl, Wiltrud Haass, Lutz Trojan, Maurice Stephan Michel, Wolf-Karsten Hofmann, Wolfgang Seifarth, Alice Fabarius
Urine from current smokers induces centrosome aberrations and spindle defects in vitro in nonmalignant human cell lines. Cancer genetics and cytogenetics 203 (2) (2011)
Gayoung Lim, Min Jin Kim, Seung Hwan Oh, Sun Young Cho, Hee Joo Lee, Jin-Tae Suh, Juhie Lee, Woo-In Lee, Kyung Sam Cho, Tae Sung Park
Acute myeloid leukemia associated with t(1;3)(p36;q21) and extreme thrombocytosis: a clinical study with literature review. Cancer genetics and cytogenetics 203 (2) (2011)
Ulrike Bacher, Torsten Haferlach, Wolfgang Kern, Tamara Alpermann, Susanne Schnittger, Claudia Haferlach
Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma. Cancer genetics and cytogenetics 203 (2) (2011)
Maliheh Hashemi Nezhad, Norbert Drieschner, Sabrina Helms, Anke Meyer, Mahboobeh Tadayyon, Markus Klemke, Gazanfer Belge, Sabine Bartnitzke, Käte Burchardt, Christiane Frantzen, Ernst Heinrich Schmidt, Jörn Bullerdiek
6p21 rearrangements in uterine leiomyomas targeting HMGA1. Cancer genetics and cytogenetics 203 (2) (2011)
Kenichiro Uchida, Atsunori Oga, Takamitsu Mano, Hitoshi Nagatsuka, Yoshiya Ueyama, Kohsuke Sasaki
Screening for DNA copy number aberrations in mucinous adenocarcinoma arising from the minor salivary gland: two case reports. Cancer genetics and cytogenetics 203 (2) (2011)
Ludger Sellmann, Rene Scholtysik, Markus Kreuz, Sandra Cyrull, Enrico Tiacci, Jens Stanelle, Alexander Carpinteiro, Holger Nückel, Tanja Boes, Stefan Gesk, Reiner Siebert, Ludger Klein-Hitpass, Ulrich Dührsen, Jan Dürig, Ralf Küppers
Gene dosage effects in chronic lymphocytic leukemia. Cancer genetics and cytogenetics 203 (2) (2011)
Cristina Motlló, Javier Grau, Jordi Juncà, Neus Ruiz, José-Luis Mate, Elisa Orna, José-Tomás Navarro, Susana Vives, Juan-Manuel Sancho, Daniel Esteban, Isabel Granada, Evarist Feliu, Josep-Maria Ribera, Fuensanta Millá
Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma. Cancer genetics and cytogenetics 203 (2) (2011)
Parinda A Mehta, Richard E Harris, Stella M Davies, Mi-Ok Kim, Robin Mueller, Beatrice Lampkin, Jun Mo, Kasiani Myers, Teresa A Smolarek
Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia. Cancer genetics and cytogenetics 203 (2) (2011)
Jess Tyson, Tamsin M O Majerus, Susan Walker, John A L Armour
Screening for common copy-number variants in cancer genes. Cancer genetics and cytogenetics 203 (2) (2011)
Anna Talamo, Yves Chalandon, Alfio Marazzi, Martine Jotterand
Clonal heterogeneity and chromosomal instability at disease presentation in high hyperdiploid acute lymphoblastic leukemia. Cancer genetics and cytogenetics 203 (2) (2011)
Zhengfei Shan, Peng Wu, Shaobin Zheng, Wanlong Tan, Haikuan Zhou, Yi Zuo, Huan Qi, Peng Zhang, Hongmei Peng, Yanfen Wang
Evaluation of upper urinary tract tumors by FISH in Chinese patients. Cancer genetics and cytogenetics 203 (2) (2011)
Monika Gupta, J Ashok Kumar, Usha Sitaram, S Neeraj, A Nancy, Poonkuzhali Balasubramanian, Aby Abraham, Vikram Mathews, Auro Viswabandya, Biju George, Mammen Chandy, Alok Srivastava, Vivi M Srivastava
The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases. Cancer genetics and cytogenetics 203 (2) (2011)
Avery A Sandberg, Aurelia M Meloni-Ehrig, Herman Van den Berghe, Paola Dal Cin, Annemarie W Block
Editorial communication. Cancer genetics and cytogenetics 203 (2) (2011)
Elisa Tassano, Angela Rita Sementa, Elisa Tavella, Alberto Garaventa, Claudio Panarello, Cristina Morerio
Trisomy 17 in congenital plexiform (multinodular) cellular schwannoma. Cancer genetics and cytogenetics 203 (2) (2011)
Hyojin Chae, Myungshin Kim, Jihyang Lim, Yonggoo Kim, Kyungja Han, Seok Lee
B lymphoblastic leukemia with ETV6 amplification. Cancer genetics and cytogenetics 203 (2) (2011)
Bella Bielorai, Claus Meyer, Luba Trakhtenbrot, Hana Golan, Esther Rozner, Ninette Amariglio, Shai Izraeli, Rolf Marschalek, Amos Toren
Therapy-related acute myeloid leukemia with t(2;11)(q37;q23) after treatment for osteosarcoma. Cancer genetics and cytogenetics 203 (2) (2011)
Hye Ryun Lee, Bora Oh, Dae Sik Hong, Dae Young Zang, Hwi-Joong Yoon, Hyeoung Joon Kim, Inho Kim, Jae-Sook Ahn, June-Won Cheong, Kyung-A Lee, Kyung Sam Cho, Mark Hong Lee, Soo-Mee Bang, Tae Young Kim, Yeo-Min Yun, Yoo Hong Min, You Kyoung Lee, Dong Soon Lee, null null
Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization. Cancer genetics and cytogenetics 203 (2) (2011)
Maria Angeles Jimenez-Sousa, Maria Teresa Ferro, Maria Talavera, Concepcion Villalon, Pablo Cabello, Jose Laraña, Pilar Herrera, Jose Miguel Garcia Sagredo
Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma. Cancer genetics and cytogenetics 203 (2) (2011)
Vesna Najfeld
Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications". Cancer genetics and cytogenetics 203 (2) (2011)
S Patrick Nana-Sinkam, Carlo M Croce
MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application. Cancer genetics and cytogenetics 203 (2) (2011)
Jinlan Pan, Yongquan Xue, Huiying Qiu, Suning Chen, Jun Zhang, Yafang Wu, Juan Shen, Yong Wang
A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia. Cancer genetics and cytogenetics 203 (2) (2011)
Ahmed Al-Qahtani, Tahani Al-Hazzani, Turki Al-hussain, Abdulmonem Al-Ghamdi, Hadeel Al-Mana, Saud Al-Arifi, Mohammed Al-Ahdal, Magdy Aly
Correlation between clinical characteristics, survival and genetic alterations in patients with hepatocellular carcinoma from Saudi Arabia. Cancer genetics and cytogenetics 203 (2) (2011)
Stephanie A Smoley, Daniel L Van Dyke, Neil E Kay, Nyla A Heerema, Marie L Dell' Aquila, Paola Dal Cin, Prasad Koduru, Ayala Aviram, Laura Rassenti, John C Byrd, Kanti R Rai, Jennifer R Brown, Andrew W Greaves, Jeanette Eckel-Passow, Donna Neuberg, Thomas J Kipps, Gordon W Dewald
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium. Cancer genetics and cytogenetics 203 (2) (2011)

volume 203, number 1, 2010

Madson Q Almeida, Constantine A Stratakis
Solid tumors associated with multiple endocrine neoplasias. Cancer genetics and cytogenetics 203 (1) (2010)
Ad Geurts van Kessel
The 'omics' of cancer. Cancer genetics and cytogenetics 203 (1) (2010)
Heather R Sanders, Maher Albitar
Somatic mutations of signaling genes in non-small-cell lung cancer. Cancer genetics and cytogenetics 203 (1) (2010)
Christopher Alexander French
NUT midline carcinoma. Cancer genetics and cytogenetics 203 (1) (2010)
Paola Caria, Roberta Vanni
Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia. Cancer genetics and cytogenetics 203 (1) (2010)
Ramprasath Venkatachalam, Marjolijn J L Ligtenberg, Nicoline Hoogerbrugge, Diederik R H de Bruijn, Roland P Kuiper, Ad Geurts van Kessel
The epigenetics of (hereditary) colorectal cancer. Cancer genetics and cytogenetics 203 (1) (2010)

volume 202, number 2, 2010

Jonghyeon Choi, Jaewoo Song, Sue Jung Kim, Jong Rak Choi, Soo Jung Kim, Yoo Hong Min, Tae Sung Park, Sun Young Cho, Min Jin Kim
Prognostic significance of trisomy 6 in an adult acute myeloid leukemia with t(8;21). Cancer genetics and cytogenetics 202 (2) (2010)
Etienne Rouleau, Cédrick Lefol, Virginie Moncoutier, Laurent Castera, Claude Houdayer, Sandrine Caputo, Ivan Bièche, Monique Buisson, Sylvie Mazoyer, Dominique Stoppa-Lyonnet, Catherine Noguès, Rosette Lidereau
A missense variant within BRCA1 exon 23 causing exon skipping. Cancer genetics and cytogenetics 202 (2) (2010)
Ali Naderi
Microdeletion of 22q11.1 is associated with two cases of familial nonsyndromic basal cell carcinoma. Cancer genetics and cytogenetics 202 (2) (2010)
Yasuyuki Gen, Kohichiroh Yasui, Yoh Zen, Keika Zen, Osamu Dohi, Mio Endo, Kazuhiro Tsuji, Naoki Wakabayashi, Yoshito Itoh, Yuji Naito, Masafumi Taniwaki, Yasuni Nakanuma, Takeshi Okanoue, Toshikazu Yoshikawa
SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma. Cancer genetics and cytogenetics 202 (2) (2010)
Maria D Iniesta, Michael A Gorin, Ling-Chen Chien, Samantha M Thomas, Kara J Milliron, Julie A Douglas, Sofia D Merajver
Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America. Cancer genetics and cytogenetics 202 (2) (2010)